Total Payments
$1.1M
2024 Payments
$349,027
Companies
14
Transactions
1,085
Medicare Patients
9,322
Medicare Billing
$372,890
Payment Breakdown by Category
Other$765,150 (72.0%)
Consulting$145,019 (13.7%)
Travel$132,055 (12.4%)
Food & Beverage$19,900 (1.9%)
Education$159.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $726,150 | 212 | 68.4% |
| Consulting Fee | $145,019 | 46 | 13.7% |
| Travel and Lodging | $132,055 | 470 | 12.4% |
| Honoraria | $39,000 | 10 | 3.7% |
| Food and Beverage | $19,900 | 343 | 1.9% |
| Education | $159.91 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $377,153 | 348 | $0 (2024) |
| United Therapeutics Corporation | $221,381 | 286 | $0 (2024) |
| Merck Sharp & Dohme LLC | $157,169 | 129 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $141,269 | 159 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $97,766 | 58 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $44,828 | 51 | $0 (2024) |
| Inari Medical, Inc. | $17,110 | 39 | $0 (2023) |
| Vertex Pharmaceuticals Incorporated | $4,583 | 8 | $0 (2023) |
| Medtronic, Inc. | $472.50 | 1 | $0 (2021) |
| GE HEALTHCARE | $160.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $349,027 | 401 | Actelion Pharmaceuticals US, Inc. ($114,481) |
| 2023 | $244,314 | 265 | Actelion Pharmaceuticals US, Inc. ($105,487) |
| 2022 | $299,263 | 291 | Actelion Pharmaceuticals US, Inc. ($97,757) |
| 2021 | $94,886 | 65 | United Therapeutics Corporation ($32,215) |
| 2020 | $54,906 | 37 | Actelion Pharmaceuticals US, Inc. ($33,886) |
| 2019 | $12,155 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($11,893) |
| 2018 | $7,710 | 13 | Bayer HealthCare Pharmaceuticals Inc. ($7,482) |
| 2017 | $21.56 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($21.56) |
All Payment Transactions
1,085 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardiology | ||||||
| 12/07/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $52.60 | General |
| 12/05/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,840.00 | General |
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $44.05 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $37.08 | General |
| 12/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,030.00 | General |
| Category: Rheumatology | ||||||
| 12/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $224.63 | General |
| Category: Rheumatology | ||||||
| 12/03/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $131.76 | General |
| 12/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Rheumatology | ||||||
| 12/03/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $18.75 | General |
| 11/25/2024 | United Therapeutics Corporation | — | Consulting Fee | Cash or cash equivalent | $8,515.00 | General |
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $902.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $318.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $269.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $118.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $115.46 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $30.99 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $28.42 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $18.94 | General |
| 11/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $403.41 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,526 | 2,949 | $309,330 | $87,441 |
| 2022 | 18 | 2,796 | 3,311 | $352,156 | $96,647 |
| 2021 | 19 | 2,569 | 2,998 | $389,922 | $122,230 |
| 2020 | 15 | 1,431 | 1,663 | $231,428 | $66,573 |
Total Patients
9,322
Total Services
10,921
Medicare Billing
$372,890
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 142 | 169 | $53,800 | $16,867 | 31.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 270 | 275 | $52,027 | $13,901 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 194 | 194 | $36,703 | $9,928 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 104 | $23,826 | $9,572 | 40.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 922 | 1,219 | $25,306 | $7,403 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $16,789 | $5,126 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 75 | $17,412 | $5,012 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 43 | $13,454 | $3,988 | 29.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $9,002 | $2,744 | 30.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 38 | 38 | $9,991 | $2,183 | 21.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 23 | $3,648 | $1,411 | 38.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 26 | 26 | $6,893 | $1,355 | 19.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 229 | 244 | $5,065 | $1,287 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,632 | $1,249 | 22.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 13 | $3,669 | $996.60 | 27.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 44 | 44 | $2,870 | $725.56 | 25.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 34 | 34 | $2,653 | $659.60 | 24.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 13 | 13 | $2,396 | $641.76 | 26.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 59 | 60 | $7,458 | $531.59 | 7.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 46 | 46 | $1,972 | $501.86 | 25.4% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 75 | 75 | $1,568 | $390.60 | 24.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 32 | 32 | $3,978 | $273.23 | 6.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $835.92 | $204.30 | 24.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 16 | 16 | $611.42 | $163.65 | 26.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 68 | 68 | $962.88 | $151.83 | 15.8% |
About John Ryan, MBBCHBAO
John Ryan, MBBCHBAO is a Cardiovascular Disease healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902071673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Ryan, MBBCHBAO has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $349,027 received in 2024. These payments were reported across 1,085 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($726,150).
As a Medicare-enrolled provider, Ryan has provided services to 9,322 Medicare beneficiaries, totaling 10,921 services with total Medicare billing of $372,890. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Salt Lake City, UT
- Active Since 04/24/2008
- Last Updated 12/30/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902071673
Products in Payments
- UPTRAVI (Drug) $343,957
- Arcalyst (Drug) $141,269
- VERQUVO (Drug) $107,642
- Adempas (Drug) $91,820
- TYVASO (Drug) $78,145
- Inpefa (Drug) $44,819
- OPSUMIT (Drug) $32,264
- WINREVAIR (Biological) $27,864
- ORENITRAM (Drug) $25,009
- CT THROMBECTOMY SYSTEM KIT (Device) $12,428
- REMODULIN (Drug) $7,506
- FLOWTRIEVER CATHETER, S (Device) $4,683
- Indigo System (Device) $127.27
- Optimizer (Device) $119.47
- TREPROSTINIL (Drug) $84.17
- BRILINTA (Drug) $48.59
- Verquvo (Drug) $24.50
- BRIDION (Drug) $15.99
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salt Lake City
Robert Fowles, M.d, M.D
Cardiovascular Disease — Payments: $630,538
Cardiovascular Disease $630,538
John Day, Md, MD
Cardiovascular Disease — Payments: $430,463
Cardiovascular Disease $430,463
Roger Freedman, Md, MD
Cardiovascular Disease — Payments: $260,682
Cardiovascular Disease $260,682
Josef Stehlik, Md, MD
Cardiovascular Disease — Payments: $169,217
Cardiovascular Disease $169,217
James Fang
Cardiovascular Disease — Payments: $161,617
Cardiovascular Disease $161,617
Dr. Jeffrey Osborn, M.d, M.D
Cardiovascular Disease — Payments: $156,668
Cardiovascular Disease $156,668